Companies / AEON Biopharma, Inc.

AEON Biopharma, Inc.

NYSE: AEONCIK 1837607ALISO VIEJO, CA

Financials

Revenue
Net income$-39.22M
Total debt
Cash$3.43M
Diluted EPS$-3.95
Shares outstanding49.9M

Ownership

49.9M shares outstanding · as of Aug 6, 2026
16.3%Insiders
Ownership
Insiders16.29%8,127,299
Institutions4.97%2,481,485
Public float78.73%39,274,006

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 9

View all →
Insider% of sharesShares
Bancroft Robert E.CEOPRESIDENT & CEO · Director
6.37%3,177,103
Oh ChadCHIEF MEDICAL OFFICER
4.38%2,183,436
Wilson Alexander BlairFormerCLO, CSO, and Corp Secretary
4.38%2,183,005
Sy JenniferPRINCIPAL ACCOUNTING OFFICER
3.01%1,501,176
Fischer JostDirector
0.98%489,469
0.52%258,705
0.52%258,705
0.52%258,705

Institutional holders 24

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 17, 2026Carter Eric G
Director
GrantClass A Common Stock$0+223K
+618.21%
258,705
0.52% of shares
low
Jun 17, 2026Fischer Jost
Director
GrantClass A Common Stock$0+223K
+83.47%
489,469
0.98% of shares
low
Jun 17, 2026Thunen Shelley B
Director
GrantClass A Common Stock$0+223K
+618.21%
258,705
0.52% of shares
low
Jun 17, 2026Palmisano Robert J
Director
GrantClass A Common Stock$0+223K
+618.21%
258,705
0.52% of shares
low
Mar 4, 2026Oh Chad
Executive
GrantClass A Common Stock$0+1.3M
+151.96%
2,183,436
4.38% of shares
low
Feb 17, 2026Oh Chad
Executive
GrantClass A Common Stock$0+863K
+21222.93%
866,564
1.74% of shares
low
Mar 4, 2026Wilson Alexander Blair
Executive
GrantClass A Common Stock$0+1.3M
+152.04%
2,183,005
4.38% of shares
low
Feb 17, 2026Wilson Alexander Blair
Executive
GrantClass A Common Stock$0+863K
+23740.71%
866,133
1.74% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
AEONCommon StockEquity00791X209BBG00Z17HDW3